Medical Virologist based at the Botswana Harvard AIDS Institute Partnership (BHP). He is the laboratory director for the Botswana Harvard HIV Reference Laboratory and a Research Associate with the Harvard T.H Chan School of Public health. He is currently part of the presidential task team for COVID-19 as a co-chief scientist.
He has made several significant contributions in laboratory systems strengthening, the prevention of mother-to-child HIV transmission studies and studies that have informed birth outcomes, the health of HIV-exposed infants, surveillance of HIV incidence, and monitoring of HIV mutations associated with drug resistance. His research interests are focused on the characterization of acute and primary HIV-1 subtype C infection, HIV cure, molecular epidemiology of HIV-1C infection, viral evolution, design and evaluation of cross-sectional methods for estimating HIV incidence, including improved accuracy and incorporating analysis of HIV diversity and estimation of transmission time into multi-assay algorithms. He is involved in various pathogen genomics studies including HIV, SARS-COV-2, Hepatitis, Human Papillomavirus, TB, and Norovirus. He is currently mentoring several students. Recently Dr Moyo and his team contributed to the identification of the Omicron variant in Southern Africa. He has over 150 publications in peer-reviewed journals.
